[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-371883-105":59,"doc-detail-371883-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","novel-small-molecules-downregulate-cdk1-expression-and-inhibit-wnt-catenin-signaling-in-cutaneous-squamous-cell-carcinoma-by-targeting-its-distinct-tumor-specific-cellular-landscape-article-open","Novel small molecules downregulate CDK1 expression and inhibit Wnt/β-catenin signaling in cutaneous squamous cell carcinoma by targeting its distinct tumor-specific cellular landscape - ARTICLE OPEN","","Novel small molecules KY19382 and KY19334 are investigated for their ability to suppress Wnt/β-catenin signaling in cutaneous squamous cell carcinoma. The study links inhibition of malignant phenotype to downregulation of cyclin-dependent kinase 1 (CDK1) expression. CDK1 and Wnt/β-catenin pathway activation are detected in patient samples versus normal controls, and CDK1 knockdown validates their role. The compounds also reduce two-stage mouse skin carcinogenesis.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/novel-small-molecules-downregulate-cdk1-expression-and-inhibit-wnt-catenin-signaling-in-cutaneous-squamous-cell-carcinoma-by-targeting-its-distinct-tumor-specific-cellular-landscape-article-open/371883/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/novel-small-molecules-downregulate-cdk1-expression-and-inhibit-wnt-catenin-signaling-in-cutaneous-squamous-cell-carcinoma-by-targeting-its-distinct-tumor-specific-cellular-landscape-article-open/371883.png","ImageObject",300,407,{"name":92,"@type":93},"Well Done","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main finding about KY19382 and KY19334 in cutaneous squamous cell carcinoma?","Question",{"text":112,"@type":113},"KY19382 and KY19334 inhibit malignant phenotypes by blocking Wnt/β-catenin signaling in human cSCC cells, which is associated with suppression of CDK1 expression.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How is CDK1 connected to Wnt/β-catenin signaling in this study?",{"text":117,"@type":113},"CDK1 is induced in human cSCC patient samples and is followed by activation of the Wnt/β-catenin pathway. CDK1 knockdown validates its role in cellular transformation and pathway activation in cSCC cells.",{"name":119,"@type":110,"acceptedAnswer":120},"What evidence supports anticancer effects beyond cell-based results?",{"text":121,"@type":113},"The two small molecules attenuate two-stage mouse skin carcinogenesis, indicating therapeutic potential in an in vivo model.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},371883,1790216989,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},5909892210082,"https://ap-avatar.wpscdn.com/avatar/56001069da27c9f41e8?x-image-process=image/resize,m_fixed,w_180,h_180&k=1789614185077863061","[www.nature.com/emm](www.nature.com/emm)  \nARTICLE OPEN   \nNovel small molecules downregulate CDK1 expression and inhibit Wnt/β-catenin signaling in cutaneous squamous cell carcinoma by targeting its distinct tumor-speciﬁc cellular landscape  \nSoung-Hoon Lee 1 ✉, Min-Jeong Kang 1, Mi Ryung Roh2 and Kang-Yell Choi 1 ✉  \n© The Author(s) 2025  \n\n|  | The Wnt/β-catenin pathway is an attractive target for drug development in various diseases; however, efforts to target it have been limited due to its concerning role in cancer. We previously developed KY19382 and KY19334, small molecules that inhibit the cytosolic function of CXXC-type zinc ﬁnger protein 5 (CXXC5), as safe therapeutic agents to restore the suppressed Wnt/β-catenin signaling in several intractable diseases, but the effects of these small molecules on cancer have not been determined. Here, we found that KY19382 and KY19334 inhibited the manifestation of malignant phenotype by inhibiting the Wnt/β-catenin signaling of human cutaneous squamous cell carcinoma (cSCC) cells, which was associated with suppression of cyclin-dependent kinase 1\u003Cbr>(CDK1) expression. The induced expression of CDK1 and subsequent Wnt/β-catenin pathway activation were observed in human cSCC patient samples compared with normal samples, and the roles of CDK1 in cellular transformation and Wnt/β-catenin pathway activation in human cSCC cells were validated by CDK1 knockdown. Moreover, the two small molecules attenuated two-stage mouse skin carcinogenesis. Overall, KY19382 and KY19334 could be used as agents to treat cSCC and other types of cancer caused by CDK1 overexpression, as well as diseases caused by cytoplasmic accumulation of CXXC5 .\u003Cbr>Experimental & Molecular Medicine (2025) 57:1996–2009; [https://doi.org/10.1038/s12276-025-01532-y](https://doi.org/10.1038/s12276-025-01532-y) |  |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n\nGraphical Abstract  \nINTRODUCTION  \nCutaneous squamous cell carcinoma (cSCC) is the second most frequently occurring skin cancer after basal cell carcinoma and the second leading cause of skin cancer-associated mortality after malignant melanoma 1, 2. Mutations in the skin cancer driver genes such as HRAS or topical application of chemicals  \nsuch as 7,12-dimethylbenzanthracene (DMBA) and 12-O-tetradecanoylphorbol-13-acetate (TPA) can result in papillomatous tumors, which are considered as potential progenitor lesions of cSCCs3,4. Because cSCC shows a higher incidence than melanoma, developing new therapies for these diseases is important4, 5.  \n1CK Regeon Inc., Yonsei Engineering Research Park, Yonsei-ro 50, Seodaemoon-gu, Seoul, South Korea. 2Department of Dermatology, Gangnam Severance Hospital, Cutaneous Biology Research Institute, College of Medicine; Yonsei University, Seoul, South Korea. ✉ email: [greateondal84@yuhs.ac](greateondal84@yuhs.ac); [kychoi@yonsei.ac.kr](kychoi@yonsei.ac.kr)  \nReceived: 5 March 2025 Revised: 9 June 2025 Accepted: 16 June 2025  \nPublished online: 1 September 2025  \nThe Wnt/β-catenin signaling pathway plays critical roles in multiple physiological processes, including proliferation, differentiation and development6–8. The aberrant activation of the Wnt/β-catenin pathway by mutations of genes encoding its components such as APC and CTNNB1 plays a role in the tumorigenesis of several types of cancer9, 10. It also promotes migration, invasion and lymph node metastasis in head and neck squamous cell carcinoma (SCC)11. The Wnt/β-catenin pathway is precisely regulated by factors such as CXXC-type zinc ﬁnger protein 5 (CXXC5) and cyclin-dependent kinases (CDKs)12, 13.  \nWe previously demonstrated that the CXXC5, a negative regulator of the Wnt/β-catenin signaling pathway that functions via binding to an upstream Wnt signaling component, Dishevelled (Dvl), is highly expressed in the cytosol of cells in the damaged tissues of p","cbCaiu0txcjmQCHA","https://ap.wps.com/l/cbCaiu0txcjmQCHA","pdf",4104443,14,"English","# Introduction\n## Background on cSCC and Wnt/β-catenin signaling\n## Prior work targeting cytosolic CXXC5 and Dvl\n## KY19382 and KY19334 rationale and prior therapeutic context","[{\"question\":\"What is the main finding about KY19382 and KY19334 in cutaneous squamous cell carcinoma?\",\"answer\":\"KY19382 and KY19334 inhibit malignant phenotypes by blocking Wnt/β-catenin signaling in human cSCC cells, which is associated with suppression of CDK1 expression.\"},{\"question\":\"How is CDK1 connected to Wnt/β-catenin signaling in this study?\",\"answer\":\"CDK1 is induced in human cSCC patient samples and is followed by activation of the Wnt/β-catenin pathway. CDK1 knockdown validates its role in cellular transformation and pathway activation in cSCC cells.\"},{\"question\":\"What evidence supports anticancer effects beyond cell-based results?\",\"answer\":\"The two small molecules attenuate two-stage mouse skin carcinogenesis, indicating therapeutic potential in an in vivo model.\"}]","Novel small molecules downregulate CDK1 expression and inhibit Wnt/β-catenin signaling in cutaneous squamous cell carcinoma by targeting its distinct tumor-specific cellular landscape - ARTICLE OPEN | PDF",1790193098,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a884aadb3975e60670a9803497c15379.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f493c59c38bcdcfed6bb9e79df7706a4.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ebb10f78c6bf72698147b1c57e322b3c.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/abcbfc3bde5f5107f54e54e4a1bb67b2.webp",980,1301]